Accessibility Menu
Spectral Ai logo

Spectral Ai(NASDAQ) MDAI

Market Cap$52.19MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-83%
5 Year-83%
1 Year-37%
1 Month-4%
$1.65
+0.3%
+0.01Today
Spectral Ai last closing stock price
MetricPriceDate
Last closeUSD 1.642026-07-27
Spectral Ai stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.61%USD 1.652026-07-20
1 month-4.09%USD 1.712026-06-26
3 month-17.17%USD 1.982026-04-28
Year to date+15.49%USD 1.422025-12-31
1 year-36.92%USD 2.602025-07-25
3 year-84.72%USD 10.732023-07-28
5 year-83.02%USD 9.662021-07-28
Since inception-83.09%USD 9.702021-04-06

Spectral Ai Financials at a Glance

Market Cap

$52.19MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$16.70M

Net Income (TTM)

-$14.29M

EPS (TTM)

-$0.53

P/E Ratio

-3.07

Dividend

$0.00

Beta (Volatility)

0.52 (Low)

Price

$1.65

Volume

1,884

Open

$1.67

Previous Close

$1.65

Daily Range

$1.65 - $1.68

52-Week Range

$1.18 - $2.97

Estimated Earnings Date

Aug 11, 2026

MDAI News

Foolcom-Featured.png

Spectral Ai Posts 32% Revenue Drop in Q2

Motley Fool Markets TeamAug 13, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Spectral Ai

Spectral AI uses artificial intelligence to help doctors assess wounds quickly. Its main products support faster decisions for burn and diabetic foot ulcer care. Hospitals and clinics use these tools to improve patient treatment planning.

Products and Services

  • DeepView System: AI-powered imaging device for wound healing assessment; targets hospitals and burn centers (100% of 2025 revenue from government contracts, not commercial sales).
  • DeepView SnapShot M: Portable, handheld diagnostic tool for emergency, military, and home healthcare settings.
  • 3D Wound Measurement: Software for three-dimensional wound and burn area measurement; supports clinical decision-making.
  • SaaS Licensing: Planned software-as-a-service model for image analysis and algorithm updates; not yet commercialized.

Growth and Expansion

  • Secured major U.S. government contracts, including a new BARDA award in 2023.
  • Achieved UKCA regulatory approval for DeepView in the UK in March 2024.
  • Submitted De Novo FDA application for U.S. market entry in June 2025.
  • Expanded product line to include handheld and 3D wound measurement tools since 2023.
  • Formed partnerships with leading medical institutions for clinical validation and commercialization support.

What Makes Spectral AI Stand Out

Spectral AI holds a large, proprietary wound image database, supporting its AI algorithms. The company relies on government funding and partnerships for research and development. Its patented technology and regulatory progress create barriers for new competitors.

Five Things You Need to Know

  • Revenue was $19.7 million in 2025, down 33.6% from 2024.
  • Gross profit reached $8.9 million in 2025, with a 45.4% margin.
  • Operating loss was $8.6 million in 2025, up from $6.6 million in 2024.
  • BARDA contracts made up 90% of 2025 revenue; no commercial sales yet.

Bottom Line

Spectral AI has evolved through government-backed research and regulatory milestones. The company remains focused on AI-driven wound diagnostics, with future growth tied to commercial product launches.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

65

CEO

Vincent S. Capone, MBA, CPA

Website

www.spectral-ai.com

Headquarters

Dallas, TX 75201, US

MDAI Financials

Key Financial Metrics (TTM)

Gross Margin

44.73%

Operating Margin

-59.39%

Net Income Margin

-85.58%

Return on Equity

179.24%

Return on Capital

-197.00%

Return on Assets

-80.58%

Earnings Yield

-32.57%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$52.19MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

31.82M

Volume

1.88K

Avg. Volume

574.57K

Financials (TTM)

Gross Profit

$7.47M

Operating Income

-$9.92M

EBITDA

-$12.72M

Operating Cash Flow

-$12.14M

Capital Expenditure

$0.00

Free Cash Flow

-$12.14M

Cash & ST Invst.

$11.66M

Total Debt

$9.94M

Spectral Ai Performance Analysis

Spectral Ai annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 25,368,000N/A
20232023-12-31USD 18,056,000-28.8%
20242024-12-31USD 29,581,00063.8%
20252025-12-31USD 19,650,000-33.6%
Spectral Ai sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-24.5%
Q32025-09-30-25.1%
Q42025-12-311.5%
Q12026-03-313.7%
Spectral Ai annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.22226.5%
20232023-12-31USD -1.48567.7%
20242024-12-31USD -0.85-42.9%
20252025-12-31USD -0.29-66.2%
Spectral Ai sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-381.8%
Q32025-09-3058.1%
Q42025-12-31116.2%
Q12026-03-31-621.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$3.99M

-40.5%

Gross Profit

$2.03M

-36.0%

Gross Margin

50.79%

N/A

Market Cap

$52.19MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$802.94K

N/A

Employees

65

N/A

Net Income

-$3.41M

-217.8%

EBITDA

-$3.06M

-186.1%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$11.66M

-17.1%

Total Debt

$9.94M

+1.9%

Accounts Receivable

$1.19M

-43.7%

Inventory

$831.00K

+90.2%

Long Term Debt

$5.27M

-41.7%

Short Term Debt

$4.67M

+550.0%

Return on Assets

-80.58%

N/A

Return on Invested Capital

2.80%

N/A

Free Cash Flow

-$3.73M

-147.7%

Operating Cash Flow

-$3.73M

-147.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ECORelectroCore, Inc.
$6.05-2.26%
SRTSSensus Healthcare, Inc.
$3.02-0.33%
TELOTelomir Pharmaceuticals, Inc. Common Stock
$1.23+6.96%
COEPCoeptis Therapeutics Holdings, Inc.
$10.99-8.57%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.25+0.10%
NOKNokia
$9.28+0.02%
AALAmerican Airlines Group
$14.95+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.24-0.02%

Questions About MDAI

What is the current price of Spectral Ai?

Spectral Ai is trading at $1.65 per share.

What is the 52-week range for Spectral Ai?

Over the past 52 weeks, Spectral Ai has traded between $1.18 and $2.97.

How much debt does Spectral Ai have?

As of the most recent reporting period, Spectral Ai reported total debt of $9.94M.

How much cash does Spectral Ai have on hand?

Spectral Ai reported $11.66M in cash and cash equivalents in its most recent financial results.

What is Spectral Ai’s dividend yield?

Spectral Ai does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services